Thromboembolic Risk Stratification by TRiP(Cast) Score to Guide Physicians in Preventive Treatment Prescriptions for Patients With Lower Limb Trauma Requiring Brace or castING. (CASTING)
Primary Purpose
Lower Limb Trauma, Venous Thromboembolism, Stratification
Status
Completed
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
TRIPscore
Sponsored by
About this trial
This is an interventional prevention trial for Lower Limb Trauma
Eligibility Criteria
Inclusion Criteria:
- Consultation in one of the emergency department participating in the study,
- Isolated trauma from lower limb,
- Rigid (plaster or resin) or semi-rigid immobilization for an assumed duration of at least 7 days,
- Adults (18 years),
- Affiliated patient or beneficiary of a social security,
- Patient with prior informed consent.
Exclusion Criteria:
- Patient with anticoagulant treatment at the time of trauma,
- Trauma requiring hospitalization of more than 48 hours,
- Co-morbidity(s) requiring hospitalization of more than 48 hours at the time of inclusion,
- Any factor making 90-day follow-up impossible,
- Pregnant, nursing or childbearing patient,
- Patient deprived of liberty by judicial or administrative decision,
- Patient undergoing psychiatric care under duress,
- Patient subject to a legal protection measure,
- Patient unable to give free and informed consent.
Sites / Locations
- Clinique Universitaire Saint-Luc
- Centre Hospitalier d'Agen
- CHU Angers
- Centre Hospitalier de Cholet
- Centre Hospitalier Universitaire de Grenoble
- Centre Hospitalier Le Mans
- Centre Hospitalier Universitaire de Nantes
- Centre Hospitalier d'Orléans
- APHP Bichat
- APHP Cochin
- Centre Hospitalier Universitaire de Poitiers
- Centre Hospitalier Universitaire de Rennes
- Centre Hospitalier de Saint-Brieuc
- Centre Hospitalier Universitaire de Toulouse
- Centre Hospitalier Universitaire de Tours
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Active Comparator
Arm Label
neutral
TRIPscore
Arm Description
No specific instructions for prescribing prophylaxis or not
calculation of the TRIPcast score and prescription of prophylactic or not according to the result (score > or = 7 : treatment (low molecular weight heparin or fondaparinux); score < 7 : no treatment)
Outcomes
Primary Outcome Measures
Rate of symptomatic venous thromboembolic events (deep vein thrombosis and / or pulmonary embolism) among patients with a TRiP(cast) score < 7
To demonstrate the reliability and safety of the decision not to implement thromboprophylaxis in patients with orthopedic immobilization for lower extremity trauma and Trip(cast) < 7
Secondary Outcome Measures
Rate of prescription for thromboprophylaxis
comparison between the two period
Rate of symptomatic venous thromboembolic events (deep vein thrombosis and / or pulmonary embolism) (whole population)
comparison between the two period
The rate of complications of preventive anticoagulant treatment (bleeding)
comparison between the two period
The direct cost of preventive anticoagulant treatment when the TRiP(cast) score is applied compared to current practices
treatment, nurse, blood test...cost of care
Physicians' satisfaction using likert's scale
5 level ladder : from totally unsatisfied to totally satisfied
Full Information
NCT ID
NCT04064489
First Posted
August 19, 2019
Last Updated
August 8, 2022
Sponsor
University Hospital, Angers
Collaborators
Centre Hospitalier de Cholet, Centre Hospitalier de Saint-Brieuc, Bichat Hospital, Hôpital Cochin, University Hospital, Toulouse, University Hospital, Grenoble, Centre Hospitalier Régional d'Orléans, Poitiers University Hospital, Nantes University Hospital, Cliniques universitaires Saint-Luc- Université Catholique de Louvain, University Hospital, Tours, CHU Rennes - Hopital Pontchaillou, Centre Hospitalier le Mans, Centre Hospitalier d'Agen
1. Study Identification
Unique Protocol Identification Number
NCT04064489
Brief Title
Thromboembolic Risk Stratification by TRiP(Cast) Score to Guide Physicians in Preventive Treatment Prescriptions for Patients With Lower Limb Trauma Requiring Brace or castING.
Acronym
CASTING
Official Title
Thromboembolic Risk Stratification by TRIP Score (Cast) to Guide Physicians in Preventive Treatment Prescriptions for Patients With Lower Limb Trauma Requiring Brace or Casting.
Study Type
Interventional
2. Study Status
Record Verification Date
August 2022
Overall Recruitment Status
Completed
Study Start Date
June 16, 2020 (Actual)
Primary Completion Date
February 4, 2022 (Actual)
Study Completion Date
February 4, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Angers
Collaborators
Centre Hospitalier de Cholet, Centre Hospitalier de Saint-Brieuc, Bichat Hospital, Hôpital Cochin, University Hospital, Toulouse, University Hospital, Grenoble, Centre Hospitalier Régional d'Orléans, Poitiers University Hospital, Nantes University Hospital, Cliniques universitaires Saint-Luc- Université Catholique de Louvain, University Hospital, Tours, CHU Rennes - Hopital Pontchaillou, Centre Hospitalier le Mans, Centre Hospitalier d'Agen
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Non-surgical traumas to the lower limbs that require orthopedic immobilisation (plaster or splint) are a frequent reason for going to accident and emergency. Due to venous stasis caused by immobilisation, hypercoagulable states and vascular injuries brought on by the trauma, these patients are at risk of developing VTE. For this reason, it is current practice in France and Belgium for the majority of patients to receive a preventative anticoagulant treatment. However, the benefit of this treatment, which has a considerable cost, is controversial. Contrary to French recommendations, American recommendations from 2012 actually advise against systematic preventative medicine, with prevention appearing to be effective primarily in studies with restrictive inclusion criteria. The most significant randomised controlled study on the subject did not show the benefit of low-molecular-weight heparin (LMWH) on the rate of symptomatic VTE among 1,435 non-selected patients. Therefore, in 2017, the Cochrane meta-analysis concluded that stratification of the risk of thromboembolism is required.
For this purpose, in collaboration with the Dutch team of Nemeth et al. we have recently developed a risk stratification model that takes into consideration the patient's characteristics, the type of immobilisation and the severity of the trauma: the TRiP(cast) score. This score is applied retrospectively to a large cohort and demonstrates excellent prognostic performances (AUC (area under the curve) of 0.74). In addition, when using a <7 limits, it makes it possible to identify a large group of patients at very low risk of developing VTE (negative predictive value: 99.2%).
The aim of the CASTING study is to prospectively demonstrate the reliability and utility of the TRiP(cast) score by showing that patients with orthopaedic immobilisation of a lower limb who are not receiving preventative treatment on the basis of a TRiP(cast) score of <7 have a very low rate of symptomatic VTE, which allows for a significant reduction in prescriptions of anticoagulants in comparison with prior practices.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lower Limb Trauma, Venous Thromboembolism, Stratification
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Sequential Assignment
Masking
Outcomes Assessor
Allocation
Non-Randomized
Enrollment
2123 (Actual)
8. Arms, Groups, and Interventions
Arm Title
neutral
Arm Type
No Intervention
Arm Description
No specific instructions for prescribing prophylaxis or not
Arm Title
TRIPscore
Arm Type
Active Comparator
Arm Description
calculation of the TRIPcast score and prescription of prophylactic or not according to the result (score > or = 7 : treatment (low molecular weight heparin or fondaparinux); score < 7 : no treatment)
Intervention Type
Other
Intervention Name(s)
TRIPscore
Intervention Description
TRIPcast score calculation
Primary Outcome Measure Information:
Title
Rate of symptomatic venous thromboembolic events (deep vein thrombosis and / or pulmonary embolism) among patients with a TRiP(cast) score < 7
Description
To demonstrate the reliability and safety of the decision not to implement thromboprophylaxis in patients with orthopedic immobilization for lower extremity trauma and Trip(cast) < 7
Time Frame
Day 90
Secondary Outcome Measure Information:
Title
Rate of prescription for thromboprophylaxis
Description
comparison between the two period
Time Frame
Day 1
Title
Rate of symptomatic venous thromboembolic events (deep vein thrombosis and / or pulmonary embolism) (whole population)
Description
comparison between the two period
Time Frame
Day 90
Title
The rate of complications of preventive anticoagulant treatment (bleeding)
Description
comparison between the two period
Time Frame
Day 90
Title
The direct cost of preventive anticoagulant treatment when the TRiP(cast) score is applied compared to current practices
Description
treatment, nurse, blood test...cost of care
Time Frame
Day 90
Title
Physicians' satisfaction using likert's scale
Description
5 level ladder : from totally unsatisfied to totally satisfied
Time Frame
Day 1
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Consultation in one of the emergency department participating in the study,
Isolated trauma from lower limb,
Rigid (plaster or resin) or semi-rigid immobilization for an assumed duration of at least 7 days,
Adults (18 years),
Affiliated patient or beneficiary of a social security,
Patient with prior informed consent.
Exclusion Criteria:
Patient with anticoagulant treatment at the time of trauma,
Trauma requiring hospitalization of more than 48 hours,
Co-morbidity(s) requiring hospitalization of more than 48 hours at the time of inclusion,
Any factor making 90-day follow-up impossible,
Pregnant, nursing or childbearing patient,
Patient deprived of liberty by judicial or administrative decision,
Patient undergoing psychiatric care under duress,
Patient subject to a legal protection measure,
Patient unable to give free and informed consent.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Pierre-Marie Roy, MD PhD
Organizational Affiliation
University Hospital, Angers
Official's Role
Study Chair
Facility Information:
Facility Name
Clinique Universitaire Saint-Luc
City
Bruxelles
Country
Belgium
Facility Name
Centre Hospitalier d'Agen
City
Agen
Country
France
Facility Name
CHU Angers
City
Angers
Country
France
Facility Name
Centre Hospitalier de Cholet
City
Cholet
Country
France
Facility Name
Centre Hospitalier Universitaire de Grenoble
City
Grenoble
Country
France
Facility Name
Centre Hospitalier Le Mans
City
Le Mans
Country
France
Facility Name
Centre Hospitalier Universitaire de Nantes
City
Nantes
Country
France
Facility Name
Centre Hospitalier d'Orléans
City
Orléans
Country
France
Facility Name
APHP Bichat
City
Paris
Country
France
Facility Name
APHP Cochin
City
Paris
Country
France
Facility Name
Centre Hospitalier Universitaire de Poitiers
City
Poitiers
Country
France
Facility Name
Centre Hospitalier Universitaire de Rennes
City
Rennes
Country
France
Facility Name
Centre Hospitalier de Saint-Brieuc
City
Saint-Brieuc
Country
France
Facility Name
Centre Hospitalier Universitaire de Toulouse
City
Toulouse
Country
France
Facility Name
Centre Hospitalier Universitaire de Tours
City
Tours
Country
France
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
Individual participant data will not be available. The study protocol, the Statistical Analysis Plan, Informed consent form will be available immediately following publication. No end date.
Citations:
PubMed Identifier
34183341
Citation
Douillet D, Riou J, Thoma M, Moumneh T, Darsonval A, Trinh-Duc A, Hugli O, Chauvin A, Penaloza A, Roy PM. Thromboembolic risk stratification by TRiP(cast) score to rationalise thromboprophylaxis in patients with lower leg trauma requiring immobilisation: a study protocol of the casting stepped-wedge cluster randomised trial. BMJ Open. 2021 Jun 28;11(6):e045905. doi: 10.1136/bmjopen-2020-045905.
Results Reference
derived
Learn more about this trial
Thromboembolic Risk Stratification by TRiP(Cast) Score to Guide Physicians in Preventive Treatment Prescriptions for Patients With Lower Limb Trauma Requiring Brace or castING.
We'll reach out to this number within 24 hrs